149 related articles for article (PubMed ID: 11598480)
1. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.
Kim JH; Sarani B; Orkin BA; Young HA; White J; Tannebaum I; Stein S; Bennett B
Dis Colon Rectum; 2001 Oct; 44(10):1496-502. PubMed ID: 11598480
[TBL] [Abstract][Full Text] [Related]
2. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.
Place RJ; Gregorcyk SG; Huber PJ; Simmang CL
Dis Colon Rectum; 2001 Apr; 44(4):506-12. PubMed ID: 11330577
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
4. [Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis].
Vatra B; Sobhani I; Aparicio T; Girard PM; Puy Montbrun TD; Housset M; Baillet F; Hecht F; Chossidow D; Soulé JC
Gastroenterol Clin Biol; 2002 Feb; 26(2):150-6. PubMed ID: 11938066
[TBL] [Abstract][Full Text] [Related]
5. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.
Stadler RF; Gregorcyk SG; Euhus DM; Place RJ; Huber PJ; Simmang CL
Dis Colon Rectum; 2004 Aug; 47(8):1305-9. PubMed ID: 15484343
[TBL] [Abstract][Full Text] [Related]
6. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
[TBL] [Abstract][Full Text] [Related]
7. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.
Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF
J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149
[TBL] [Abstract][Full Text] [Related]
8. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
9. Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy?
Martin D; Balermpas P; Fokas E; Rödel C; Yildirim M
Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):248-255. PubMed ID: 28049602
[TBL] [Abstract][Full Text] [Related]
10. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
[TBL] [Abstract][Full Text] [Related]
11. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
[TBL] [Abstract][Full Text] [Related]
12. Anal squamous cell carcinoma in KwaZulu-Natal Province, South Africa, with special reference to the influence of HIV infection on clinical presentation and management outcome.
Zuma NP; Ngidi S; Madiba TE
S Afr Med J; 2020 Feb; 110(3):243-248. PubMed ID: 32657703
[TBL] [Abstract][Full Text] [Related]
13. Time-dose considerations in the treatment of anal cancer.
Constantinou EC; Daly W; Fung CY; Willett CG; Kaufman DS; DeLaney TF
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):651-7. PubMed ID: 9336145
[TBL] [Abstract][Full Text] [Related]
14. Anal carcinoma: a 15-year retrospective analysis.
Olofinlade O; Adeonigbagbe O; Gualtieri N; Gingold B; Berlin I; Sayeed R; Robilotti J
Scand J Gastroenterol; 2000 Nov; 35(11):1194-9. PubMed ID: 11145292
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
[TBL] [Abstract][Full Text] [Related]
16. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
17. HIV and anal cancer outcomes: a single institution's experience.
Hogg ME; Popowich DA; Wang EC; Kiel KD; Stryker SJ; Halverson AL
Dis Colon Rectum; 2009 May; 52(5):891-7. PubMed ID: 19502853
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience.
Hammad N; Heilbrun LK; Gupta S; Tageja N; Philip PA; Shields AF; Smith D; El-Rayes BF
Am J Clin Oncol; 2011 Apr; 34(2):135-9. PubMed ID: 20523206
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.
Peddada AV; Smith DE; Rao AR; Frost DB; Kagan AR
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1101-5. PubMed ID: 9169819
[TBL] [Abstract][Full Text] [Related]
20. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
